Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.8 USD | -10.02% | -2.55% | +105.61% |
Mar. 18 | Transcript : Lantern Pharma Inc., Q4 2023 Earnings Call, Mar 18, 2024 | |
Mar. 18 | Lantern Pharma Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+105.61% | 94.52M | |
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |
- Stock
- Equities
- Stock Lantern Pharma Inc. - Nasdaq
- News Lantern Pharma Inc.
- Lantern Pharma : to Join Forces With Brain Cancer Program at Johns Hopkins to Further Develop Brain Cancer Drug Candidate LP-184